Genetic correction will be a standard method for the patient-derived ips cell research?
Department of Neurology, Kyoto University Graduate School of Medicine, Japan.
Ryosuke
R
Takahashi
Hodaka
H
Yamakado
D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism*; D006801:Humans; D057026:Induced Pluripotent Stem Cells / Q000378:metabolism*; D010300:Parkinson Disease / Q000235:genetics* / Q000378:metabolism*; D017346:Protein Serine-Threonine Kinases / Q000235:genetics*
D017346:Protein Serine-Threonine Kinases; D048049:Extracellular Signal-Regulated MAP Kinases